A Retrospective Review of Ruxolitinib as Acute Graft-Versus-Host Disease Prophylaxis in Pediatric Patients with Transplant Associated Thrombotic Microangiopathy
Background: Graft-versus-host disease (GVHD) represents a significant complication following allogeneic hematopoietic stem cell transplantation (HSCT), with tacrolimus being a standard prophylactic agent. However, tacrolimus is associated with transpl
Authors
- Richard Howrey
- Heidi Trinkman
- Vivian Ho (ORCID: https://orcid.org/0000-0002-5979-8155)
- Berhanu Seyoum
- David Farbo
Institutions
- Cook Children's Medical Center (US)
Publication Details
- Published
- 2025-07-18
- DOI
- https://doi.org/10.22541/au.175282399.92042490/v1
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00